Remembering Emil von Behring: from Tetanus Treatment to Antibody Cooperation with Phagocytes - PubMed (original) (raw)

Editorial

Remembering Emil von Behring: from Tetanus Treatment to Antibody Cooperation with Phagocytes

Stefan H E Kaufmann. mBio. 2017.

Abstract

A century ago, Emil von Behring passed away. He was the first to be honored by the Nobel Prize for Medicine in 1901 for the successful therapy of diphtheria and tetanus, which he had developed from the bench to the bed. He also contributed to the foundation of immunology, since his therapy was based on passive immunization with specific antisera. Being an ambitious character, he did not shy away from friction with his colleagues Paul Ehrlich and Elias Metchnikoff and his mentor, Robert Koch. Behring was not only an excellent translational researcher but also a successful entrepreneur and early proponent of public-private partnerships.

Copyright © 2017 Kaufmann.

PubMed Disclaimer

Figures

FIG 1

FIG 1

Timeline showing highlights of Emil Behring’s work as savior of children and wounded soldiers. DMW, Deutsche Medizinische Wochenschrift.

Similar articles

Cited by

References

    1. Behring E, Kitasato S. 1890. Über das Zustandekommen der Diphtherie-Immunität und der Tetanus-Immunität bei Thieren. Dtsch Med Wochenschrift 49:1113–1114. - PubMed
    1. Behring E. 1890. Untersuchungen ueber das Zustandekommen der Diphtherie-Immunität bei Thieren. Dtsch Med Wochenschrift 50:1145–1148. - PubMed
    1. Behring E. 1893. Die Geschichte der Diphtherie (mit besonderer Berücksichtigung der Immunitätslehre). Verlag von Georg Thieme, Leipzig, Germany.
    1. Behring E. 1913. Über ein neues Diphtherieschutzmittel. Dtsch Med Wochenschrift 19:873–876.
    1. Smith T. 1909. Active immunity produced by so called balanced or neutral mixtures of diphtheria toxin and antitoxin. J Exp Med 11:241–256. doi:10.1084/jem.11.2.241. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

Personal name as subject

LinkOut - more resources